Effects of structural integration Rolfing® method and acupuncture on fibromyalgia

Fibromyalgia is a syndrome that affects millions of people worldwide and is characterized primarily by chronic widespread pain that persists for more than three months. This condition has a significant impact on patients' quality of life, frequently producing mood changes, nonrestorative sleep, muscle stiffness, and fatigue disproportionate to physical effort. In addition to the physical aspects, fibromyalgia is associated with elevated levels of anxiety and depression, creating a complex cycle in which emotional symptoms can intensify pain and vice versa. Because of this multifaceted nature, treatment of fibromyalgia traditionally requires a multidisciplinary approach, combining different therapies to address the various aspects of the condition.

A Brazilian study conducted at the Multidisciplinary Pain Center of the Hospital das Clinicas of the University of Sao Paulo (USP) investigated two promising complementary therapies for the treatment of fibromyalgia: the Rolfing method of structural integration and acupuncture. The research aimed to evaluate whether these techniques, applied individually or in combination, could effectively reduce pain, improve anxiety and depression symptoms, and increase the quality of life of fibromyalgia patients. The Rolfing method, developed by American biochemist Ida Pauline Rolf, works through structural reorganization of the body via myofascial release and movement reeducation, seeking to improve body alignment and musculoskeletal function. Acupuncture, an ancient technique from traditional Chinese medicine, uses needles inserted at specific points on the body to regulate the flow of energy and treat imbalances that cause pain and disease.

The study involved sixty patients diagnosed with fibromyalgia, who were randomly divided into three groups of twenty each. The first group received only acupuncture, with ten weekly sessions of twenty minutes each, using eighteen needles at specific points related to fibromyalgia tender points. The second group received the Rolfing method exclusively, also with ten weekly sessions of thirty minutes each, focused on myofascial release and movement reeducation. The third group received the combination of both therapies, completing the ten Rolfing sessions and the ten acupuncture sessions on the same day.

All participants continued their conventional medical treatment during the study period, ensuring that essential care was not interrupted.

To measure outcomes, the researchers used scientifically validated instruments, applied at three time points: before treatment, immediately after the end of the sessions, and three months later. Pain was assessed with the Verbal Numerical Pain Scale, on which patients rated their pain from zero (no pain) to ten (unbearable pain). Symptoms of anxiety and depression were measured with the Beck Anxiety and Depression Inventories, self-administered questionnaires. Quality of life was assessed with the Fibromyalgia Impact Questionnaire, on which lower scores indicate better quality of life.

The results were highly encouraging, showing statistically significant improvement in all measures evaluated across the three treatment groups. Pain, which initially showed very high levels in all groups, was substantially reduced after treatment. In the acupuncture group, mean pain decreased from 8.85 to 4.65 points, remaining at 5.47 three months after the end of treatment. In the Rolfing group, the reduction was similar, going from 8.90 to 4.55 and remaining at 5.72 after three months.

The group that received the combination of the two therapies had the best results for pain, with a decrease from 8.80 to 3.45, remaining at 4.85 at follow-up. Symptoms of anxiety and depression also showed substantial improvements in all groups, with reductions that remained stable during the follow-up period.

Particularly notable was the observation that, although there was a small increase in pain three months after the end of treatment compared with the end of the sessions, the benefits remained significantly better than baseline levels. This suggests that both therapies provide lasting effects, not merely temporary relief. Quality of life improved substantially in all groups, indicating that patients were able to resume activities and experience greater overall well-being.

The clinical implications of these findings are significant for patients and health care professionals. For patients with fibromyalgia, the study offers scientific evidence that complementary therapies can be valuable tools in managing the condition. Both the Rolfing method and acupuncture proved to be safe and effective as adjunctive treatments and can be incorporated into the multidisciplinary therapeutic plan. It is important to emphasize that these therapies do not replace conventional medical treatment but rather complement it synergistically.

The Rolfing approach, by working with body awareness and movement reeducation, provides patients with tools to better understand and manage their pain. Acupuncture, in turn, provides relief through energetic rebalancing, offering a holistic perspective on healing.

For health care professionals, the study reinforces the importance of considering integrative approaches in the treatment of fibromyalgia. The evidence that combining therapies may be more effective than isolated treatments supports the current trend toward personalized and multidisciplinary medicine. Physicians, physical therapists, and other professionals may consider referring patients for these complementary treatments, especially when conventional methods do not provide adequate relief or when the goal is to reduce dependence on medications.

It is essential to acknowledge the study's limitations for an appropriate interpretation of the results. The relatively small number of participants in each group may have limited the ability to detect more subtle differences between the treatments. The three-month follow-up duration, although meaningful, does not allow conclusions about long-term effects. The absence of a placebo control group represents a methodologic limitation, although understandable given the practical characteristics of the interventions studied.

In addition, it was not possible to keep patients and therapists blinded to the type of treatment received, which may influence results through expectations and biases.

Despite these limitations, the study still provides valuable evidence about the therapeutic potential of the Rolfing method and acupuncture in fibromyalgia. The research suggests that these complementary approaches deserve further investigation and clinical consideration, particularly in a context where treatment options for fibromyalgia remain limited and not always fully effective. The fact that both therapies demonstrated lasting benefits, with good tolerability and no reported adverse effects, strengthens their safety profile and clinical applicability. For patients seeking alternatives or complements to conventional treatment, this study offers hope and direction based on solid scientific evidence.